Dermata Therapeutics (DRMA) Non-cash Items (2022 - 2025)
Dermata Therapeutics (DRMA) posted quarterly Non-cash Items of -$111826.0 for Q3 2025, up 54.5% year-over-year from -$72379.2 in Q3 2024, and up 88.7% quarter-over-quarter from -$989388.0 in Q2 2025.
Dermata Therapeutics (DRMA) Non-cash Items (2022 - 2025) Analysis & Trends
Dermata Therapeutics' Non-cash Items history runs 4 years deep, the most recent figure standing at -$111826.0 for Q3 2025.
- In Q3 2025, Non-cash Items rose 54.5% year-over-year to -$111826.0; the TTM figure through Sep 2025 stood at -$494369.0 (down 126.38% YoY), while the FY2024 annual figure was $1.1 million, down 18.85% from the prior year.
- Non-cash Items for Q3 2025 stood at -$111826.0, up from -$989388.0 in the prior quarter.
- The five-year high for Non-cash Items was $986668.0 in Q4 2023, with the low at -$989388.0 in Q2 2025.
- The 4-year median for Non-cash Items is $178304.0 (2022), against an average of $170355.2.
- The sharpest annual moves came in 2023 and 2024: Non-cash Items soared 732.78% in 2023, then plunged 368.88% in 2024.
- Dermata Therapeutics' Non-cash Items stood at -$155926.0 in 2022, then jumped by 732.78% to $986668.0 in 2023, then slumped by 75.95% to $237324.0 in 2024, then tumbled by 147.12% to -$111826.0 in 2025.
- Business Quant data shows DRMA's Non-cash Items at -$111826.0 in Q3 2025, -$989388.0 in Q2 2025, and $369521.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -111,826.00 |
| Sep 30, 2025 | -111,826.00 |
| Jun 30, 2025 | -989,388.00 |
| Jun 30, 2025 | -989,388.00 |
| Mar 31, 2025 | 369,521.00 |
| Mar 31, 2025 | 369,521.00 |
| Dec 31, 2024 | 237,324.00 |
| Dec 31, 2024 | 237,324.00 |
| Sep 30, 2024 | -245,772.00 |
| Sep 30, 2024 | -245,772.00 |
| Jun 30, 2024 | 703,153.00 |
| Jun 30, 2024 | 703,153.00 |
| Mar 31, 2024 | 429,808.00 |
| Mar 31, 2024 | 429,808.00 |
| Dec 31, 2023 | 986,668.00 |
| Dec 31, 2023 | 986,668.00 |
| Sep 30, 2023 | -52,417.00 |
| Sep 30, 2023 | -52,417.00 |
| Jun 30, 2023 | -139,001.00 |
| Jun 30, 2023 | -139,001.00 |